We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+4.45%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$9.86B
AUM Growth
-$168M
Cap. Flow
-$326M
Cap. Flow %
-3.31%
Top 10 Hldgs %
9.48%
Holding
825
New
63
Increased
274
Reduced
363
Closed
64

Top Buys

Rank Stock Value
1
JJSF icon
J&J Snack Foods
JJSF
+$29.7M
2
WDFC icon
WD-40
WDFC
+$28.7M
3
CBZ icon
CBIZ
CBZ
+$27.6M
4
EXPO icon
Exponent
EXPO
+$19.4M
5
ANDG
Andersen Group
ANDG
+$19.3M

Sector Composition

Rank Sector Weight
1 Industrials 25.96%
2 Technology 18.79%
3 Financials 16.43%
4 Consumer Discretionary 12.93%
5 Healthcare 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AOUT icon
426
American Outdoor Brands
AOUT
$158M
$6.13M 0.06%
792,439
-66,794
-8% -$495K
INDI icon
427
indie Semiconductor
INDI
$668M
$6.06M 0.06%
1,716,960
+40,200
+2% +$176K
PBH icon
428
Prestige Consumer Healthcare
PBH
$2.37B
$6.03M 0.06%
97,750
+39,685
+68% +$2.43M
BLND icon
429
Blend Labs
BLND
$424M
$6.01M 0.06%
1,978,135
+306,895
+18% +$979K
SLNO
430
DELISTED
Soleno Therapeutics
SLNO
$5.97M 0.06%
129,043
+98,056
+316% +$5.38M
GDYN icon
431
Grid Dynamics Holdings
GDYN
$590M
$5.97M 0.06%
+661,131
New +$5.73M
FLOC
432
Flowco Holdings
FLOC
$825M
$5.97M 0.06%
318,500
+35,500
+13% +$592K
ACU icon
433
Acme United Corp
ACU
$214M
$5.94M 0.06%
147,403
-8,427
-5% -$324K
BCC icon
434
Boise Cascade
BCC
$2.65B
$5.89M 0.06%
80,000
-24,400
-23% -$1.78M
ASC icon
435
Ardmore Shipping
ASC
$703M
$5.88M 0.06%
555,530
-184,000
-25% -$2.19M
SIBN icon
436
SI-BONE Inc
SIBN
$798M
$5.84M 0.06%
296,067
+134,016
+83% +$2.33M
PAL
437
Proficient Auto Logistics
PAL
$187M
$5.83M 0.06%
+605,290
New +$4.75M
JBL icon
438
Jabil
JBL
$32.3B
$5.81M 0.06%
25,474
-12,391
-33% -$2.64M
CORT icon
439
Corcept Therapeutics
CORT
$12.7B
$5.8M 0.06%
166,562
-1,997
-1% -$157K
BRK.B icon
440
Berkshire Hathaway Class B
BRK.B
$1.1T
$5.78M 0.06%
11,500
MCFT icon
441
MasterCraft Boat Holdings
MCFT
$597M
$5.78M 0.06%
305,466
+48,764
+19% +$962K
HAE icon
442
Haemonetics
HAE
$3.85B
$5.73M 0.06%
71,475
-629,767
-90% -$42.3M
KHC icon
443
Kraft Heinz
KHC
$31.3B
$5.7M 0.06%
235,000
+25,000
+12% +$622K
GRDN
444
Guardian Pharmacy Services
GRDN
$2.61B
$5.6M 0.06%
186,122
-82,015
-31% -$2.32M
ODC icon
445
Oil-Dri
ODC
$1.42B
$5.55M 0.06%
113,314
+17,614
+18% +$976K
MRVI icon
446
Maravai LifeSciences
MRVI
$996M
$5.54M 0.06%
1,706,149
-55,615
-3% -$187K
BTSG icon
447
BrightSpring Health Services
BTSG
$14.3B
$5.53M 0.06%
147,539
-34,999
-19% -$1.17M
AXGN icon
448
Axogen
AXGN
$2.2B
$5.5M 0.06%
168,039
-33,005
-16% -$812K
NMIH icon
449
NMI Holdings
NMIH
$3.3B
$5.45M 0.06%
133,590
-694
-0.5% -$26.2K
MD icon
450
Pediatrix Medical
MD
$2.17B
$5.45M 0.06%
254,748
+75,702
+42% +$1.55M

Similar funds

Royce & Associates's Q4 2025 Portfolio in Review

As of Q4 2025, Royce & Associates held 825 positions worth $9.86B, down 1.7% from $10B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Royce & Associates withdrew a net $326M in Q4 2025, closing 64 positions and reducing 363 holdings. Its most notable exit was Charles River Laboratories, an estimated $13.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in J&J Snack Foods worth $29.6M.

  • Royce & Associates's largest Q4 2025 buy was J&J Snack Foods: 327,501 shares worth $29.6M.
  • Royce & Associates added most to WD-40 in Q4 2025, an estimated $28.7M increase.
  • Royce & Associates's biggest Q4 2025 reduction was Haemonetics, cutting an estimated $42.3M.
  • Royce & Associates fully exited Charles River Laboratories in Q4 2025, selling an estimated $13.2M.
  • Royce & Associates's ten largest holdings make up 9.5% of its $9.86B portfolio in Q4 2025.
  • Royce & Associates opened 63 new positions and closed 64 in Q4 2025.
  • Royce & Associates's portfolio value fell 1.7% quarter-over-quarter to $9.86B.

Based on Royce & Associates's 13F filing for Q4 2025, filed 9 Feb 2026.